Literature DB >> 18466098

Pharmacogenetic response to albuterol among asthmatics.

Harriet Corvol1, Esteban González Burchard.   

Abstract

Pharmacogenetics offers to individualize asthma treatment by identifying genetic variants associated with drug efficacy or adverse events. Several studies have focused on pharmacogenetic associations with albuterol, the most commonly prescribed medication for asthma worldwide. However, pharmacogenetic associations have varied within and between studies and across populations. Herein, we focus on pharmacogenetic associations between genetic variants in the beta(2)-adrenergic receptor gene and bronchodilator response to albuterol among subjects with asthma.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18466098     DOI： 10.2217/14622416.9.5.505

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


  7 in total

1.  Polymorphism in Osteopontin Gene (SPP1) Is Associated with Asthma and Related Phenotypes in a Puerto Rican Population.

Authors:  Mehrdad Arjomandi; Josh M Galanter; Shweta Choudhry; Celeste Eng; Donglei Hu; Kenneth Beckman; Rocío Chapela; José R Rodríguez-Santana; William Rodríguez-Cintrón; Jean Ford; Pedro C Avila; Esteban G Burchard
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2011-12       Impact factor: 1.349

2.  Factors predicting inhaled corticosteroid responsiveness in African American patients with asthma.

Authors:  Wendy Gould; Edward L Peterson; Gloria Karungi; Amanda Zoratti; John Gaggin; Ghazwan Toma; Shiqing Yan; Albert M Levin; James J Yang; Karen Wells; Mingqun Wang; Robert R Burke; Kenneth Beckman; Danijela Popadic; Susan J Land; Rajesh Kumar; Max A Seibold; David E Lanfear; Esteban G Burchard; L Keoki Williams
Journal:  J Allergy Clin Immunol       Date:  2010-12       Impact factor: 10.793

3.  Development of a pharmacogenetic-guided warfarin dosing algorithm for Puerto Rican patients.

Authors:  Alga S Ramos; Richard L Seip; Giselle Rivera-Miranda; Marcos E Felici-Giovanini; Rafael Garcia-Berdecia; Yirelia Alejandro-Cowan; Mohan Kocherla; Iadelisse Cruz; Juan F Feliu; Carmen L Cadilla; Jessica Y Renta; Krystyna Gorowski; Cunegundo Vergara; Gualberto Ruaño; Jorge Duconge
Journal:  Pharmacogenomics       Date:  2012-12       Impact factor: 2.533

4.  Pharmacogenomics of pediatric asthma.

Authors:  Sarika Gupta; Shally Awasthi
Journal:  Indian J Hum Genet       Date:  2010-09

5.  Molecular insights into the dynamics of pharmacogenetically important N-terminal variants of the human β2-adrenergic receptor.

Authors:  Ganesh Shahane; Chirag Parsania; Durba Sengupta; Manali Joshi
Journal:  PLoS Comput Biol       Date:  2014-12-11       Impact factor: 4.475

Review 6.  Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine.

Authors:  Afsoon Sepahzad; Deborah J Morris-Rosendahl; Jane C Davies
Journal:  Genes (Basel)       Date:  2021-04-13       Impact factor: 4.096

7.  SLC26A9 Gene Is Associated With Lung Function Response to Ivacaftor in Patients With Cystic Fibrosis.

Authors:  Harriet Corvol; Julie Mésinèle; Isman-Hassan Douksieh; Lisa J Strug; Pierre-Yves Boëlle; Loïc Guillot
Journal:  Front Pharmacol       Date:  2018-07-26       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.